FGFR2 and cholangiocarcinoma: 12 In cholangiocarcinoma, an International Cancer Genome Consortium (ICGC) study showed FGFR2 mutations in 12 of 417 (2.9%) analyzed patients.13 One of the 12 patients had the FGFR2 p.Ser252Trp mutation.